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Abstract. 
Prion diseases are infectious neurodegenerative diseases associated with the misfolding, aggregation and deposition of host prion protein (PrP) in the brain. These diseases include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease (CWD) in deer, and Creutzfeldt-Jakob disease (CJD) in humans. The infectious agent is thought to be composed solely of a misfolded form of PrP (PrPSc) that propagates by binding and converting host PrP into the abnormal conformation. Natural routes of transmission appear to be oral, but disease can also be spread by intravenous, intracerebral or peripheral exposure. Human prion diseases, such as CJD, were generally considered to have a spontaneous or familial (linked to mutations in the prion protein gene) aetiology, although subsequent iatrogenic transmission has been demonstrated in some cases. Risks posed to humans from prion diseases in animals were therefore thought to be low. The emergence of BSE in the UK was followed by the appearance of a new variant of human prion disease (vCJD), and transmission studies in rodents confirmed the two diseases were caused by the same strain of prion agent. These data proved that some ruminant prion diseases could be zoonotic, and a potential risk to humans may exist from new and emerging prion agents in ruminants. Indeed analysis and characterisation of recently identified prion isolates in ruminants (atypical scrapie, H-type BSE, L-type BSE and chronic wasting disease) has revealed that some may pose a risk of transmission to humans, and are still a concern to public health. 


Keywords
Prion; TSE; zoonosis; BSE; atypical prion


Review Methodology
Literature referenced in this article was sourced from searches of PubMed and Web of Science. Keyword terms searched included “BSE, atypical BSE, atypical scrapie, CWD, primate, human, zoonosis”. Articles were also selected from the author’s existing reference archive resource and from discussions with colleagues.

Review Text.
Introduction.
Prion diseases are fatal, infectious, neurodegenerative diseases of man and animals. These include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease (CWD) in deer and elk,  and Creutzfeldt-Jakob disease (CJD) in humans. Prion diseases are a member of the family of diseases linked with the misfolding and aggregation of host protein in the brain, such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease. However, what makes prion diseases unique is their infectious nature and the ability to transmit directly between animals of the same and different species.  The infectious agent is thought to consist solely of an abnormally folded and aggregated form (PrPSc) of the normal host prion glyco-protein (PrPC ) []. It is hypothesised that this misfolded form can propagate by binding to and converting normal PrPC into the abnormal conformation []. Hence, this infectious agent is unconventional in that it appears to encode strain specific information in protein structure without an additional informational molecule such as DNA or RNA.  The true nature of the agent has yet to be fully defined, however the infectious nature of prion diseases has made them a serious concern for public health.

Are prion diseases a risk to humans?
Several forms of human prion disease exist, many of which are thought to be familial and linked to mutations in the human PrP gene (PRNP). These include Gerstmann-Sträussler-Scheinker (GSS) disease, fatal familial insomnia (FFI) and familial CJD (fCJD)  ADDIN EN.CITE [, ]. Other human prion diseases appear to have a sporadic nature, such as sporadic CJD (sCJD)  ADDIN EN.CITE [] and are thought to arise spontaneously within the brain of the individual. Although it has been demonstrated that some human prion diseases are transmissible, few cases have been linked to an infectious aetiology. Most cases of acquired human disease have been linked with surgical intervention (presumably with contaminated instruments previously used on individuals with familial or sporadic forms of the disease)  ADDIN EN.CITE [, ], administration of prion-contaminated growth hormone, dura-matter grafts  ADDIN EN.CITE [, ], or blood transfusion from donors subsequently found to develop vCJD  ADDIN EN.CITE []. Direct transmission of human prion disease has been documented in the Fore tribe in Papua New Guinea where a disease known as Kuru was identified that was transmitted between members of the tribe following ritualistic cannibalism  ADDIN EN.CITE []. This established that oral transmission of prions between humans was indeed possible.
Ruminant prion disease has been present in the sheep and goat population for many hundreds of years, with the first documented case of scrapie in the UK in 1732 []. As the rate of sCJD is approximately 1 per million population worldwide, and no epidemiological evidence of increased cases was observed in counties with or without endemic natural scrapie, it was assumed that ruminant prions posed little risk to humans. The emergence of BSE in the UK in the 1980s  ADDIN EN.CITE [, ] was followed in 1996 by the description of a new variant of CJD (vCJD) [] exhibiting different clinical and pathological phenotypes than cases of sCJD and fCJD. In particular the disease was being identified in much younger individuals than was usually the case for CJD  ADDIN EN.CITE [, ].  Further analyses of vCJD isolates confirmed this was a prion disease, was transmissible and was caused by the same strain of agent as that responsible for BSE in cattle  ADDIN EN.CITE [, ]. It was therefore assumed that the agent had transmitted to humans via consumption of food contaminated with the BSE agent. There have been 177 deaths from vCJD in the UK (National CJD Research and Surveillance Unit, Edinburgh. Data, July 2014; http://www.cjd.ed.ac.uk/data.html), with a peak of 28 deaths in 2000. Following the introduction of feed bans in 1988  ADDIN EN.CITE [, ] preventing the recycling of cattle material in animal feed, and the removal of affected tissues (specified risk material; SRM) in the food chain from 1989 [], cases of BSE and subsequently cases of vCJD have declined significantly. Only 1 death was reported from vCJD in 2013, and no cases have been documented to date in 2014 (Data from National CJD Research and Surveillance Unit, Edinburgh. http://www.cjd.ed.ac.uk/data.html). In cattle tested in 2013, three cases of BSE were identified from 191,000 samples. No cases have yet been identified in 2014 (61,000 samples), although the 2014 data include only 55 healthy slaughter animals >48 months of age due to changes in regulatory testing (data from Defra; http://www.defra.gov.uk/ahvla-en/publication/tse-active-surv-stats/) 
Although cases of vCJD are now rare, the true extent of exposure to the agent and the prevalence of subclinical infection in the human population are unknown. Unlike BSE in cattle, peripheral agent replication has been demonstrated for vCJD in humans  ADDIN EN.CITE [, ]. Several retrospective surveys of archived tonsil and appendix tissue have now been performed to look for evidence of PrPSc deposition in peripheral tissue  ADDIN EN.CITE []. The latest of these which sampled 32,441 tissues found 16 positive for abnormal PrP, estimating an incidence of 493 per million population (~1 in 2000)  ADDIN EN.CITE []. Whether these individuals would ever develop full-blown prion disease is questionable, but the persistence of such “silent prions” in the periphery may lead to human to human transmission of disease through procedures such as surgery and blood transfusion. 
The emergence of vCJD in the human population highlighted that some ruminant prion agents were zoonotic, and were of greater risk to humans than others. The BSE agent appears to be effective at transmitting between different species, and has been identified in domestic and exotic cats [], humans  ADDIN EN.CITE [, ], and exotic ungulates (kudu, nyala etc..)  ADDIN EN.CITE [] but not in species such as pigs  ADDIN EN.CITE [] and dogs [] which were undoubtedly exposed to significant levels of BSE during the height of the epidemic. The reasons for this wide host range are unclear, but much is thought to rely on the specific interaction between host PrP and the particular conformer/strain of the infectious prion. It therefore stands to reason that other ruminant prion agents may exist or emerge that are also transmissible to a wide range of species, including humans. As the incidence of BSE and vCJD are now declining, diagnostic testing of all cattle in the UK has been suspended and testing is now only performed on suspect animals or fallen stock (Defra policy 1st March 2013; http://www.defra.gov.uk/animal-diseases/a-z/tses/ (​http:​/​​/​www.defra.gov.uk​/​animal-diseases​/​a-z​/​tses​/​​) ). Removal of such safeguards may allow new or emerging prion infections to become established before preventative measures can be implemented.

Modelling BSE Zoonosis
Although strain-typing evidence strongly suggested that BSE was the cause of vCJD, no real evidence of direct cow to human prion transmission existed. In order to model BSE transmission in animals expressing human PrP under laboratory conditions, transgenic mouse models were engineered that expressed the human PrP gene (HuTgs) instead of the mouse PrP gene. These included lines expressing either the amino acid valine (129V-HuTg) or methionine (129M-HuTg) at codon 129 in human PrP, a polymorphism known to affect prion susceptibility in humans  ADDIN EN.CITE [, ]. All clinical cases of vCJD to date have occurred in individuals homozygous for 129-Met, indicating the importance of this polymorphism in susceptibility to the BSE agent [, ]. Considerable variation in BSE susceptibility was observed between different transgenic lines with various constructs and PrP expression levels. However, in general, transmission rates in overexpressing 129M-HuTg mice were found to be low (0-30%)  ADDIN EN.CITE [] and BSE failed to cause disease 3/3 lines of knock-in human PrP transgenic mice (HuMM, HuMV and HuVV) which expressed human PrP at the same levels as wild type mouse PrP []. Together these experiments indicated that the transmission barrier between humans and cattle was high and that the disease was not easily transmitted to humans.  This may reflect the low number of clinical cases of vCJD (177) compared to the size of the UK population that may have been exposed to the agent in the 1980s & 1990s.  Interestingly, recent studies in overexpressing 129M-HuTg mice have indicated that peripheral tissue may be more permissive to BSE infection than brain. PrPSc was detected in the spleens of 65% of mice compared to only 7% of brains following intracerebral inoculation with BSE  ADDIN EN.CITE []. Cross species transmission may therefore require a particular tissue tropism which may extend host range and help overcome species barriers. These observations may also explain the relatively high detection rate of extraneural vCJD PrPSc in tonsil and appendix studies (~1:2000) compared to the number of reported clinical vCJD cases (177)  ADDIN EN.CITE [].
The most compelling evidence for zoonotic transmission of BSE to humans has been demonstrated in transmission studies in non-human primates. While mice are good laboratory models, they are not humans and may not reflect the full genetic effect of prion susceptibility in humans. Genetically, non-human primates are more similar to humans than mice, and also outbred; but ethics of the use of these animals in research is complex. Studies have established efficient transmission of BSE to cynomolgus macaques  ADDIN EN.CITE [] and Microcebus murinus (lemurs)  ADDIN EN.CITE [] by both i.c.  ADDIN EN.CITE [, , , ] and oral challenge  ADDIN EN.CITE [, ]. Changes observed in behaviour, neurological signs and disease pathology were similar to those observed in cases of vCJD. In particular the presence of florid plaques, characteristic of vCJD, was described in several cases of primate BSE transmission  ADDIN EN.CITE [, ].

New Prion Transmission Threats.
Following the BSE outbreak, post mortem diagnostic testing and surveillance of sheep, goats and cattle for prion infection identified a number of isolates that did not conform to the phenotype of classical scrapie or BSE. It was unknown whether these “new” isolates were newly emerging or newly identified due to advances in prion diagnosis. In particular, differences were observed in the banding pattern of PrP observed by immunoblot following digestion with proteinase K (PK). While PrPC  is totally digested by PK, abnormal PrP produces a characteristic 3-band pattern (often referred to as PrP 27-30, or PrP-res) which represents the PK-resistant fragments of the di, mono, and unglycosylated forms of the protein. This pattern can vary for different forms/strains of prion, and is referred to as the PrP-res glycoform (Figure 1).
Atypical scrapie: Several “anomalous prion” isolates were identified in sheep that appeared to resemble scrapie but did not display the characteristic PrP-res glycoform on immunoblots probed with anti PrP antibodies. In 1998, a scrapie variant named Nor98 was identified [] which was transmissible and caused scrapie in sheep, but had a distinctly different glycoform banding pattern on immunoblot, where the characteristic PrP 27-30 bands were absent, and only a low molecular weight band of 8-10 kDa was visible with reduced levels of PK and specific antibody reagents (P4 and 12B2). Such isolates were identified as prion positive by newly developed diagnostic testing kits (IDEXX HerdChek Assay and BioRad TeSeE Assay) [] in which either no PK or reduced levels of PK were utilised. Subsequent surveys of archived material performed at both the Animal Health and Veterinary Laboratories Agency (AHVLA) and Institute for Animal Health/Roslin Institute have established that such atypical scrapie isolates have been present in the small ruminant population for some time  ADDIN EN.CITE [, ]. Evidence of the presence of atypical scrapie has also been demonstrated in countries classified as “scrapie free” such as Australia and New Zealand  ADDIN EN.CITE []. Whether atypical scrapie is a spontaneous form of the disease is as yet unknown. Approximately half the cases of classical scrapie identified in the EU are atypical scrapie  ADDIN EN.CITE [, ]. Atypical scrapie has been shown to be transmissible in both sheep [] and transgenic mice overexpressing sheep PrP (OvTg) instead of mouse PrP  ADDIN EN.CITE [, ]. Indeed incubation times in OvTg mice are remarkably short. The unknown presence of this agent in the sheep and goat population for many years questioned whether this prion agent may be transmissible to humans, and thus responsible for some cases of sCJD. Recent studies have described high levels of infectivity in peripheral tissues of Nor98/atypical scrapie infected animals  ADDIN EN.CITE [], leading to potential dietary exposure to humans. Transmission studies to knock-in HuTg transgenic mice (HuMM, HuMV and HiVV) [] or overexpression 129M-HuTg models expressing 4-8x the normal level of human PrP  ADDIN EN.CITE [] have to date given no evidence of atypical scrapie transmission to animals expressing human PrP.
Atypical BSE: In Italy increased prion surveillance identified two cases of bovine prion disease in older animals that differed pathologically from classical BSE []. In these cases, less deposition of PrPSc was evident in the brainstem, and widespread PrP amyloid plaques were present in the cerebrum. The PrP-res glycoform profile also differed from classical BSE following immunoblot, with a faster electrophoretic mobility of the unglycosylated fragment (Figure 1). These cases were classified as a new bovine prion disease; “Bovine Amyloidotic Spongiform Encephalopathy” (BASE), or “L-Type BSE”, due to the presence of the lower molecular mass glycoform. Following additional investigative screening in France, a further example of atypical BSE was identified in which the molecular mass of the unglycosylated PrP-res fragment was greater than that observed in both classical BSE and L-type BSE [] (Figure 1). This was termed “H-type BSE” due to the higher molecular weight fragment. Such atypical cases have now been described in Denmark, Ireland, Netherlands, UK [], France [], Germany [], Italy [], Switzerland, Poland, Japan, Brazil [], Canada and the USA  ADDIN EN.CITE [, ]. Both atypical BSE diseases were transmissible in cattle  ADDIN EN.CITE [], and mice expressing bovine PrP  ADDIN EN.CITE [, , , ]. Interestingly, these isolates appeared to be able to revert to classical BSE under some circumstances when passaged in wild type mice  ADDIN EN.CITE [, ], OvTg mice  ADDIN EN.CITE [], and occasionally in overexpressing bovine PrP transgenic mice (BovTg)  ADDIN EN.CITE []. The true relationship between these isolates is currently unknown, but links with the BSE strain indicate a potential risk of transmission to humans, as was thought to have occurred with vCJD.
Several different in vivo and in vitro approaches have been used to assess the possible risks posed to humans from atypical BSE isolates. Most have involved transmission experiments using HuTg mice. H-type BSE failed to transmit disease to both overexpressing 129M-HuTg mice [], and knock-in HuTg mice (HuMM, HuMV and HuVV) [], indicating low transmission risk of disease to humans. However L-type BSE was shown to transmit with 100% efficiency in overexpressing 129M-HuTg mice, with incubation times of >500 days []. Mixed results were obtained in knock-in transgenic mice, with clinical signs and PrP deposition observed in ~40% of inoculated Tg40 mice [], but no transmission in HuMM, HuMV or HuVV mice []. However evidence of subclinical agent replication was observed in HuMM mice following subpassage [], indicating disease transmission to these mice may have been observed if lifespan was extended.
While transgenic mice expressing human PrP provide some indication of prion transmission risk in humans, mice may respond differently than humans to prion infection. Atypical BSE transmission experiments have therefore also been performed in non-human primates to assess risk in a species more closely related to humans. L-type BSE transmitted by both i.c. inoculation (4/4) and by the oral route (5/8) to mouse lemurs  ADDIN EN.CITE [] with greater efficiency than classical BSE. Previous experiments had demonstrated classical BSE transmission to mouse lemurs only following passage in macaques (3/3 inoculated with macaque passaged BSE; 0/1 inoculated with BSE)  ADDIN EN.CITE []. Transmission was observed in both young and old animals. Transmission studies in cynomolgus macaques demonstrated disease transmission following i.c. inoculation with L-type BSE, with a substantially shorter incubation time than seen with classical BSE  ADDIN EN.CITE [, ]. No evidence of H-type BSE transmission in non-human primates has been reported.
In vitro amplification studies have also been performed to model the risk atypical BSE and atypical scrapie pose to humans. In these studies, abnormal PrPSc sourced from infected brain tissue is used to seed amplification of human PrPC in a process termed Protein Misfolding Cyclic Amplification (PMCA) [, ]. In this process, small amounts of abnormal PrPSc are mixed with substrate containing PrPC. Samples are incubated to allow interaction of seed and substrate, and conversion of PrPC to PrPSc. Aggregates formed in this conversion process are disrupted by sonication, leading to the production of new small PrPSc seeds to repeat the conversion process. This incubation and sonication is performed over multiple cycles, allowing the amplification of low levels of PrPSc to a level that can be identified by immunoblot (Figure 2.). This assay is proposed to demonstrate prion replication in vitro. In contrast to in vivo studies, PMCA amplification of classical BSE occurred efficiently in human PrPC substrate, but no amplification of H-type BSE, L-type BSE or atypical scrapie was observed  ADDIN EN.CITE []. 
Chronic Wasting Disease: Ruminant prion disease can also be found in cervid species. Chronic wasting disease (CWD) is a fatal, endemic TSE disease affecting free-ranging and captive cervids, including mule deer, white-tailed deer, Rocky Mountain elk and moose in the USA, Canada and South Korea  ADDIN EN.CITE [].  CWD is known to spread via a variety of routes  ADDIN EN.CITE [], and transmission between cervids is highly efficient [].  In addition to brain, spinal cord and lymphoid tissues  ADDIN EN.CITE [, , ], PrP-res has also been found in muscle, saliva, urine, faeces, fat, blood and antler velvet of CWD-infected cervids  ADDIN EN.CITE [].  The ease of spread within deer herds and widespread dissemination of infectivity within the animal has raised concern regarding the risk of CWD transmission to humans. 
Attempts to model CWD zoonosis using HuTg mice have revealed no evidence of disease transmission in either knock-in  ADDIN EN.CITE [, ] or overexpression  ADDIN EN.CITE [] transgenic models. Transmission studies in non-human primates showed disease transmission in squirrel monkeys inoculated with CWD infected mule deer brain 31-34 months post inoculation  ADDIN EN.CITE []. Further studies using a series of CWD infected brain pools from free ranging and captive mule deer, white tailed deer and elk confirmed transmissibility by i.c. and oral routes in squirrel monkeys, but not in cynomolgus macaques. Interestingly, CWD passaged through squirrel monkeys also failed to demonstrate transmission of disease in HuTg mice  ADDIN EN.CITE []. As humans are evolutionarily closer to macaques than squirrel monkeys these data support the hypothesis that a substantial transmission barrier exists between humans and CWD, even following primate adaptation. 
Some evidence to support a possible zoonosis of CWD has been produced through in vitro amplification studies. Limited conversion of human PrPC  by CWD was obtained in cell-free conversion assays, where purified human PrPC and CWD PrPSc were mixed directly []. Early PMCA amplification of human PrPC seeded with CWD brain homogenate failed  ADDIN EN.CITE []. However later studies by Barria and co-workers demonstrated that prior PMCA amplification of CWD prions in cervid PrPC substrate allowed subsequent PMCA amplification in human PrPC substrate  ADDIN EN.CITE []. Additionally, limited amplification of CWD PrPSc was observed in human brain, humanised transgenic mouse brain and human cell homogenate substrate  ADDIN EN.CITE []. These data suggest that CWD/human PrPC conversion is at least possible under cell-free conditions, and that given the right conditions, CWD prions may demonstrate zoonotic potential in vivo.

Existing Prion Agents in New Hosts
Due to their infectious nature, prion diseases have the ability to transmit not only between animals of the same species, but also between animals of different species. The species barrier is a phenomenon whereby a specific prion agent transmits to a new species with low efficiency and long incubation time, but displays higher levels of susceptibility and shortened incubation times on subsequent subpassage and adaptation in the new species. What precisely controls the species barrier is unknown. While PrP sequence compatibility is clearly an important factor, with the most efficient transmission occurring between animals of the same PrP genotype, it is not absolute, as agents such as BSE can transmit to several different species with high efficiency [], and hamster 263K scrapie can transmit to mice with a single amino acid mutation in murine PrP []. Such cross species transmission of existing prion agents may change host range or virulence of an agent, increasing risk.
BSE in particular has proven transmissible to several different species, including sheep and goats  ADDIN EN.CITE []. Despite being exposed to the same contaminated feed as cattle during the BSE epidemic (although at lower levels) [], no natural cases of BSE have been identified in sheep. However two cases have been described in goats  ADDIN EN.CITE [], indicating that small ruminants have been exposed to BSE. Experimental challenge with cattle BSE has confirmed that sheep and goats are both susceptible to infection by ic, oral and iv routes  ADDIN EN.CITE []. Importantly, in contrast to cattle, where infectivity is generally restricted to  tissues of the CNS, infectivity is readily detectible in sheep and goat peripheral tissues such as spleen and lymph node []. This indicates that BSE in small ruminants may pose a greater risk to public health due to the wider dissemination of infectivity in the carcass, including tissues not currently discarded as SRM. 
In order to assess whether BSE agent characteristics have been altered following passage through small ruminants, several transmission studies of experimental sheep (exp-shBSE) and goat (exp-gtBSE) BSE have been performed in wild type, HuTg and BovTg mouse models. Bioassay has shown an apparent increased virulence of exp-shBSE compared to cattle BSE (caBSE) following transmission to transgenic mice overexpressing bovine or porcine PrP  ADDIN EN.CITE [, ]. In wild type mice and knock-in BovTg mice, susceptibility to exp-shBSE was similar to caBSE, and patterns of prion specific vacuolation, PrP deposition and PrP-res glycoform were indistinguishable from caBSE  ADDIN EN.CITE []  However in all cases, incubation times were significantly shorter for both exp-shBSE and exp-gtBSE compared to caBSE  ADDIN EN.CITE [, , , ]. In knock-in HuMM mice 40-70% of mice displayed prion specific pathology following inoculation with exp-shBSE and exp-gtBSE  ADDIN EN.CITE []. This increased to 100% in overexpressing 129M-HuTg mice (6-8 fold) with many of the animals displaying clinical signs of disease. This was compared to no disease or low levels (0-30%) of disease with caBSE  ADDIN EN.CITE []. 
The reasons for the increased transmissibility of BSE to HuMM and 129M-HuTg mice following passage in sheep and goats are still unclear. It is possible that the BSE agent is able to replicate to higher levels in sheep and goat brain than in cattle brain, providing a higher dose to the recipient HuMM and 129M-HuTg mice, resulting in the reduced incubation times and increased susceptibility. However recent titration studies performed in knock-in BovTg mice demonstrated similar titres of prion infectivity in sheep and cattle BSE brainstem [], indicating increased agent titre was not responsible for the increased transmissibility to HuMM and 129M-HuTg mice. Levels of PrP-res (proteinase K resistant PrP) were also found to be lower in exp-shBSE tissue than caBSE tissue  ADDIN EN.CITE [, ], despite no significant difference in the level of infectivity present in the exp-shBSE and caBSE infected brainstem []. It is possible that the ovine/caprine PrP sequence is required to allow a more efficient interaction of the BSE agent with human 129M-PrP, however as described above, no disease transmission has been observed in HuMM mice following inoculation with several isolates of natural and atypical sheep scrapie and goat scrapie  ADDIN EN.CITE [, ], indicating that it is not simply the presence of the ovine or caprine PrP sequence that facilitates transmission to animals expressing human PrP. In vitro amplification studies have established that exp-shBSE can amplify all ovine and bovine PrPC  allelic variants by PMCA more efficiently than sheep scrapie []. Furthermore, PMCA assays have also established that human 129M-PrPC can be converted with equal efficiency by BSE PrPSc from both cattle and sheep brain tissue  ADDIN EN.CITE [], indicating that human 129M-PrP can interact and convert equally well with both sheep and cattle BSE PrP-res in a cell free environment. 

Conclusions/Summary
Despite the current decline in cases of BSE in cattle and vCJD in humans, prion diseases still occur in animals and humans. New isolates/strains of prion have been identified in ruminants, and the potential for existing isolates/strains to cross into new species will remain while prion diseases are still present in the environment.  While experimental evidence to date suggests some of these new agents may be transmissible to humans (L-type BSE, CWD, sheep and goat BSE), the real risk posed to humans via exposure to such cases of disease are still largely unknown. This may reflect the recent observation that ~1:2000 of the UK population have abnormal PrP deposits in peripheral organs. There is therefore a need to continue surveillance and characterisation of any new/emerging prion isolates in ruminants and assess the potential for zoonotic transmission.
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